Anti-Hypertensive Flashcards

1
Q

First line drugs of choice

A
Diuretics
Calcium Channel Blockers
ACE inhibitors
Angiotensin Receptor Blockers
(BB are not first line because they do not work well in AA populations, and cause significant side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diuretics

A

Drugs of choice in uncomplicated hypertension

Mild/moderate hypertension with lifestyle modification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Thiazides

A
Hydrochlorothiazide, Chlorthalidone
Inhibits Na/Cl cotransporter
Initial volume contraction
Decreased peripheral resistance (prostaglandins)
Mild Na excretory effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Loop Diuretics

A

Furosemide (Lasix)
Blocks Na/K/2Cl co-transporter in TAL
Venous dilation from prostaglandins
Dehydration/hyponatremia, hypokalemia, impaired diabetes control, increased LDL/HDL, ototoxicity
Drug interactions: NSAIDs, Aminoglycosides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

K Sparing Diuretics

A

Spironolactone, eplerenone, tramterene, amiloride
Aldosterone receptor blocker/prevent insertion of ENAC channels in collecting tubule
Side Effects: Hyperkalemia, gynecomastia (spironolactone)
Drug interactions: NSAIDs (block good effects of prostaglandins), ACE inhibitors and ARBs (also inhibit aldosterone)
Contraindications: RAS inhibitors (have both ACE inhibitors and ARBs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ca Channel Blockers

Nondihydropyridine

A

Can do heart and smooth muscle receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ca Channel Blockeres

Dihydropyridines

A

More selective for vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ca Channel Blockers

A

MoA: Reduce vascular resistance by reducing Ca influx

Non-dihydropyridine reduce pacemaker potentials, AV node conduction, and contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ca Channel Blockers

Nifedipine

A

Dihydropyridine
Limited affect on pacemaker or conduction
SE: acute tachycardia, headache, peripheral edema (arteriolar dilation > venodilation), flushing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ca Channel Blockers

Diltiazem

A

Non-dyhydropyridine
Reduces pacemaker and conduction current
SE: dizziness, headache, edema, bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ca Channel Blockers

Verapamil

A

Non-dihydropyridine
More pronounced reduction of current
SE: dizziness, headache, edema, constipation, bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CCB therapeutic Notes

A

Non-dihydropyridines are contraindicated in patients with conduction disturbances
Use non-dihydropyridine with caution in patient given B-blockers
Avoid use of short acting CCBs for chronic hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sympatholytic Drugs

A

MOA: Reduces sympathetic-mediated vasoconstriction, Co, and renin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clonidine

A

Sympatholytic Drug
Centrally acting agent
a2 adrenergic receptor agonist in medullary CV center
Decreases sympathetic outflow from CNS
SE: sedation, dry mouth, bradycardia, dermatitis
Drug interactions: CNS depressants
Withdraw slowly to prevent rebound hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Guanfacine

A

Longer half-life than clonidine

Less chance of rebound hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Methyldopa

A

Sympatholytic Drug
a2-adrenergic receptor agonist (same MOA as clonidine)
Competes wtih L-DOPA for DOPA decarboxylase
Inhibits dopamine production
Drug interactions: levodopa
SE: Sedation, nightmares, movement disorders, hyperprolactinemia, anemia
Contraindications: Liver Dx
USED IN HYPERTENSION WITH PREGGOS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Reserpine

A

Indirect Acting Adrenergic Blocking Agent
Blocks VMAT vesicular transporter
Prevents storage of NE centerally and peripherally
Combined with diuretics for mild/moderate HTN
SE: sedation, diarrhea, depression, bradycardia, nasal congestion
Drug interactions: CNS depressant, MAOIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Alpha Adrenergic Receptor Antagonists

A

Block a-adrenergic-mediated vasoconstriction at receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Phenoxybenzamine

A

Alpha adrenergic receptor antagonist
Non selective
Primary use in PHEOCHROMOCYTOMA
SE: Tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Prazosin

A

Alpha adrenergic receptor antagonist
Less tachycardia than direct vasodilators
Initial hypotension
Does not impair exercise tolerance
Terazosin and doxazosin have longer half-life
SE: Hypotension (first dose), dizziness, headaches, weakness
Also decreases LDL/HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Beta Blockers

A

Decrease cardiac contractility and CO
Decrease renin secretion
Decrease angiotensin II production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Propranolol

A

Nonselective B-blocker
Mild/moderate hypertension
Adjunct to prevent tachycardia with vasodilators
Lipophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Nadolol

A

Nonselective B-Blocker
Longer half-life than propranolol
Better compliance
Hydrophilic

24
Q

Pindolol

A
Non-selective B-Blocker
Partial agonist
Less bradycardia
Lipophilic
Good for patients who still want to exercise
25
Q

Metoprolol

A

B1-Selective
Fewer respiratory side effects
Lipophilic

26
Q

Atenolol

A

B1-Selective
Hydrophilic
Excreted by kidney

27
Q

Labetolol

A
B-Blocker
Has some a-blocker capacity
Orthostatic hypotension and sexual dysfunction
Used for pheochromocytoma
Lipophilic
28
Q

Carvedilol

A
Nonselective B-Blocker
a-receptor antagonist
vasodilator
Lipophilic
Increases NO
29
Q

BB SE

A
Bradycardia
Impotence
Increased TG
Decreased HDLs
Hyperglycemia
Impaired exercise tolerance
30
Q

BB Drug Interactions

A

CCB

Reduced contractility and conduction

31
Q

BB Contraindication

A

Cardiogenic shocks
Sinus bradycardia
Asthma
Severe Heart Failure

32
Q

BB and Diabetics

A

Can mask insulin-induced hypoglycemia

Give them ACEI instead

33
Q

Vasodilators

A

Vasodilation of arterioles

34
Q

Hydralazine

A

Vasodilator
Orally effective
Used in drug resistant hypertension and emergency
Long term use is poor
SE: Tachycardia, angina aggravation, fluid retention, nausea, vomiting, sweating, flushing, lupus-like symptoms
NSAIDs can reduce effectiveness

35
Q

Minoxidil

A

Vasodilator
Used in drug resistant hypertension
SE: Same as hydralazine including hypertrichosis (werewolf syndrome)

36
Q

Nitroprusside

A
Vasodilator
Used in emergencies (BP > 200)
Immediate onset
Brief duration
Promotes arterial and venous dilation
SE: Nausea, vomiting, muscle twitch, cyanide poisoning (from metabolites in long-term usage)
37
Q

ACE Inhibitors

A

Blocks production of angiotensin II and ATII-mediated vasoconstriction
ATII causes growth and aldosterone release
ACE inhibitors prevent breakdown of bradykinin so it can go on and increase prostaglandins and NO

38
Q

Catopril

A

ACEI
Short half life
Multiple daily doses
Active metabolites

39
Q

Enalapril

A
ACEI
Converted to active metabolite enalaprilat
Longer onset of action
Longer half life
Dose 1-2xday
40
Q

Lisinopril

A
ACEI
Water soluble
Excreted unchanged by kidney
Longer half-life
Allows 1x daily dosing
More predicitable onset and duration of action
41
Q

ACEI SE

A

Hyperkalemia
Rash
Dry cough
Angioedema

42
Q

ACEI Drug Interactions

A

Exacerbates hyperkalemic effect of K sparing drugs

43
Q

ACEI Contraindications

A

PREGGOS

Bilat renal stenosis

44
Q

ACEI Notes

A

Prolongs survival in pts with HF or LV dysfunction after MI (ATII promotes growth/inflammation so if we prevent that the heart wont get more damaged)
Preserves renal function in diabetic patients

45
Q

Angiotensin II Receptor Blockers (ARBs)

A

Mediate vasoconstriction and Na retention
Less effective in Na-sensitive hypertensiv epatients (AA_
Reduce dose in hypovolemia or live disease
Better results with diuretic combo
Effect takes 1 week

46
Q

Losartan

A

Selective ARB
SE: Hyperkalemia
Contraindications: PREGGOS (cause renal failure)
Drug interactions: exacerbates hyperkalemia in K sparing drugs

47
Q

Good Combos

A

Thiaxaide or loop diurteic with K sparing diuretic
Thiazide with BB
CCB with ACEI

48
Q

Bad Combos

A

ACEI with K sparing diuretics (exacerbate hyperkalemia)
ACEI and ARBs (no advantage in diuretics, but increased risk of hyperkalemia)
Don’t mix drugs with same MOA, efficacy won’t increase

49
Q

Diabetes mellitus

A

ACEI (delay loss of renal function)
a-blockers
CCBs (limited effects on carbohydrate metabolism)

50
Q

Hearth Failure

A

ACEIs (reduce mortality and recurrent MI)

Combine with diuretics for congestion

51
Q

MI

A

ACEIs reduce remodeling
ACEIs reduce subsequent MI
BBs (but not the partial agonist pindolol) reduce arrhythmia and remodeling

52
Q

Pregnancy

A

Avoid ACEI or ARBs and BBs (inhibits renin)

Methyldopa is widely used

53
Q

African Americans

A

Monotherapy with diuretics, CCBs most efficacious

Monotherapy with BBs and ACEIs not as effective though good control can be done through combined diuretics

54
Q

Elderly

A

Small doses with small increments
Simple regimens
Monitor side effects closely

55
Q

Diabetes mellitis

A

ACEI
A-blockers
CCBs have some effects on carbohydrate metabolism

56
Q

Hyperlipidemia

A

Low dose diuretics have little effects on cholesterol and TG
BB can raise TG
A-blockers can decrease LDL/HDL ration
CCBs, ACEIs, ARBs have little effect on lipid profile

57
Q

Obstructive Airway Disease

A

Avoid BBs